Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$803
|
$756B |
12.9x |
30.1x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$193
|
$497B |
5.4x |
14.4x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$230
|
$470B |
7.9x |
18.0x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$85
|
$239B |
3.7x |
8.2x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$539
|
$232B |
5.3x |
21.2x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$299
|
$209B |
5.9x |
11.5x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$187B |
3.0x |
7.6x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$123
|
$172B |
6.0x |
11.6x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$209
|
$164B |
6.7x |
21.3x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$44
|
$126B |
2.7x |
7.9x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$417
|
$102B |
8.6x |
22.7x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$144
|
$69.2B |
7.3x |
16.9x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$482
|
$61.6B |
18.8x |
131.6x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$578
|
$56.5B |
4.0x |
11.8x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$635
|
$51.9B |
12.5x |
36.3x |
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$205
|
$48.3B |
3.0x |
12.8x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$142
|
$42.1B |
6.1x |
21.3x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$166
|
$33.8B |
75.1x |
-33.8x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1349
|
$29.9B |
7.6x |
24.1x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$286
|
$29.7B |
2.1x |
12.6x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$190
|
$27.3B |
2.6x |
12.7x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$25.8B |
1.8x |
6.1x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$143
|
$24.8B |
2.6x |
7.7x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$182
|
$24.1B |
12.0x |
-92.0x |
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$319
|
$22.7B |
9.0x |
38.2x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$37
|
$22.5B |
7.7x |
8.1x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$335
|
$21.1B |
6.8x |
18.9x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$185
|
$17.5B |
2.2x |
10.9x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$433
|
$16.5B |
5.2x |
10.0x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$95
|
$16.1B |
3.8x |
14.1x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$15.3B |
N/A |
-42.2x |
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$528
|
$14.9B |
6.2x |
28.9x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$88
|
$14.7B |
3.1x |
12.4x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$14.3B |
3.1x |
16.3x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$140
|
$13.4B |
4.9x |
21.5x |
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$61
|
$13.3B |
4.3x |
30.2x |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$93
|
$13.2B |
4.7x |
15.6x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$136
|
$12.0B |
2.9x |
11.7x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$55
|
$11.6B |
27.7x |
-24.1x |
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$179
|
$11.4B |
2.8x |
11.8x |
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$48
|
$11.0B |
5.3x |
14.4x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$73
|
$10.8B |
12.9x |
-26.6x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.7B |
1.7x |
5.5x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$39
|
$10.0B |
4.3x |
12.0x |
Bio-Techne
|
United States of America |
Laboratory Services,
Pharma Diagnostics & Analytics
|
$62
|
$9.9B |
8.1x |
23.1x |
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$53
|
$9.4B |
3.0x |
10.9x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$105
|
$9.2B |
3.5x |
-6.3x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$439
|
$9.1B |
12.4x |
-29.7x |
Guardant Health
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$65
|
$8.9B |
10.0x |
-39.0x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$67
|
$8.8B |
7.0x |
10.7x |
Ingredion
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$121
|
$8.7B |
1.2x |
6.8x |
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$17
|
$8.6B |
N/A |
N/A |
Repligen
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$153
|
$8.6B |
12.1x |
62.4x |
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$54
|
$8.1B |
1630.2x |
-8.1x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$79
|
$8.0B |
9.7x |
N/A |
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$17
|
$7.4B |
306.1x |
-6.9x |
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$110
|
$7.2B |
40.9x |
-37.0x |
Stevanato Group
|
United States of America |
Medical Supplies,
Drug Delivery Systems
|
$24
|
$7.0B |
5.3x |
21.3x |
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$58
|
$7.0B |
99.1x |
-11.7x |
RadNet
|
United States of America |
Medical Imaging & Diagnostics,
Laboratory Services
|
$77
|
$6.9B |
3.6x |
24.0x |
Sotera Health
|
United States of America |
Laboratory Services,
Medical Supplies
|
$16
|
$6.6B |
5.8x |
11.4x |
Merus
|
United States of America |
Drug Development & Therapeutics
|
$95
|
$6.5B |
132.9x |
-19.4x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$128
|
$6.3B |
11.0x |
-38.0x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$22
|
$6.2B |
1.4x |
8.2x |
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$48
|
$5.8B |
587.3x |
-10.0x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$26
|
$5.8B |
2.7x |
-1.5x |
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$93
|
$5.7B |
N/A |
-15.2x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$5.6B |
1.9x |
8.4x |
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$35
|
$5.5B |
10.3x |
41.4x |
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$32
|
$5.3B |
5.6x |
-41.5x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$53
|
$5.0B |
N/A |
N/A |
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$190
|
$4.8B |
13.3x |
35.2x |
CRISPR Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$69
|
$4.8B |
164.2x |
-8.5x |
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$4.5B |
6.4x |
129.3x |
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$87
|
$4.4B |
68.1x |
-20.2x |
Protagonist Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$78
|
$4.3B |
31.5x |
-73.0x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$30
|
$4.1B |
2.8x |
11.0x |
Nomad Foods
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$12
|
$4.0B |
1.1x |
6.5x |
Prestige Consumer Healthcare
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$62
|
$4.0B |
3.5x |
10.7x |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$42
|
$3.9B |
N/A |
N/A |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$3.8B |
6.1x |
17.6x |
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$74
|
$3.7B |
7.8x |
-137.3x |
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$56
|
$3.7B |
2.5x |
6.3x |
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$190
|
$3.7B |
1816.1x |
-13.5x |
Kymera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$60
|
$3.7B |
50.2x |
-13.5x |
PTC Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$66
|
$3.6B |
2.4x |
5.7x |
Akero Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$54
|
$3.6B |
N/A |
-11.0x |
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$3.5B |
N/A |
N/A |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$14
|
$3.4B |
7.0x |
15.8x |
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$36
|
$3.4B |
97.6x |
N/A |
Ligand Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$182
|
$3.3B |
16.1x |
44.1x |
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$35
|
$3.3B |
34.8x |
-31.3x |
uniQure
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$58
|
$3.3B |
124.9x |
-19.9x |
Soleno Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$65
|
$3.2B |
28.3x |
N/A |
Apogee Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$55
|
$3.2B |
N/A |
-11.6x |
Apellis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$25
|
$3.2B |
3.3x |
60.5x |
Mineralys Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$44
|
$3.1B |
N/A |
-15.7x |
Viking Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$34
|
$3.0B |
N/A |
-11.2x |
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$23
|
$2.9B |
1.4x |
-15.6x |
ACADIA Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$2.8B |
2.7x |
22.6x |